Conroy, T;
Pfeiffer, P;
Vilgrain, V;
Lamarca, A;
Seufferlein, T;
O’Reilly, E. M;
Hackert, T;
Golan, T;
Prager, G;
Haustermans, K;
Vogel, A;
Ducreux, M.
The opportunity to detect pancreatic cancer (PC) when potentially curable depends on early diagnosis and an ability to identify and screen high-risk populations before symptoms arise. Identification of a high-risk population is challenging and optimal screening tools remain unclear.1 Older age is the str...
The purpose of this guideline is to provide guidance on the investigation and care of women and people with recurrent miscarriage.Within this document we use the terms woman and women's health. However, it is important to acknowledge that it is not only women for whom it is necessary to ...
Many compounding pharmacies use the phrase “bioidentical hormone” as a marketing term to imply that these preparations are natural and, thus, safer and more effective than U.S. Food and Drug Administration (FDA)–approved menopausal medications that use bioidentical or synthetic hormones or both. Ho...
Since the early 2000s, there has been a rapid
decline in colorectal cancer (CRC) mortality, due in large part
to screening and removal of precancerous polyps. Despite
these improvements, CRC remains the second leading cause
of cancer deaths in the United States, with approximately
53,000 deaths projected...
Exocrine pancreatic insufficiency (EPI) is a disorder caused by the failure of the pancreas to deliver a minimum/
threshold level of specific pancreatic digestive enzymes to the
intestine, leading to the maldigestion of nutrients and macronutrients, resulting in their variable deficiencies. EPI is freque...
Antiplatelet and antithrombotic
medication management before, during, and after
neurointerventional procedures has significant practice
variation. This document updates and builds upon the
2014 Society of NeuroInterventional Surgery (SNIS)
Guideline ’Platelet function inhibitor and platelet
function te...
Lavonas, Eric J;
Akpunonu, Peter D;
Arens, Ann M;
Babu, Kavita M;
Cao, Dazhe;
Hoffman, Robert S;
Hoyte, Christopher O;
Mazer-Amirshahi, Maryann E;
Stolbach, Andrew;
St-Onge, Maude;
Thompson, Trevonne M;
Wang, George Sam;
Hoover, Amber V;
Drennan, Ian R.
In this focused update, the American Heart Association provides updated guidance for resuscitation of patients with cardiac arrest, respiratory arrest, and refractory shock due to poisoning. Based on structured evidence reviews, guidelines are provided for the treatment of critical ...
Papi, Alberto;
Ferreira, Diogenes S.;
Agache, Ioana;
Baraldi, Eugenio;
Beasley, Richard;
Brusselle, Guy;
Coleman, Courtney;
Gaga, Mina;
Gotera Rivera, Carolina Maria;
Melén, Erik;
Pavord, Ian D.;
Peñate Gómez, Deborah;
Schuermans, Daniel;
Spanevello, Antonio;
Tonia, Thomy;
Schleich, Florence.
Recent clinical trials of as-needed fixed-dose combination of inhaled corticosteroid (ICS)/formoterol have provided new evidence that may warrant a reconsideration of current practice. A Task Force was set up by the European Respiratory Society to provide evidence-based recommendations on the use of as-n...
Ra, Jin H;
Rattan, Rishi;
Patel, Nimitt J;
Bhattacharya, Bishwajit;
Butts, Christopher A;
Gupta, Shailvi;
Asfaw, Sofya H;
Como, John J;
Sahr, Sheryl M;
Bugaev, Nikolay.
Recent studies have evaluated outcomes associated with duration of antimicrobial treatment for complicated intra-abdominal infections (cIAI). The goal of this guideline was to help clinicians better define appropriate antimicrobial duration in patients who have undergone definitive source control for cIA...
Pavlick, Anna C;
Ariyan, Charlotte E;
Buchbinder, Elizabeth I;
Davar, Diwakar;
Gibney, Geoffrey T;
Hamid, Omid;
Hieken, Tina J;
Izar, Benjamin;
Johnson, Douglas B;
Kulkarni, Rajan P;
Luke, Jason J;
Mitchell, Tara C;
Mooradian, Meghan J;
Rubin, Krista M;
Salama, April K. S;
Shirai, Keisuke;
Taube, Janis M;
Tawbi, Hussein A;
Tolley, J Keith;
Valdueza, Caressa;
Weiss, Sarah A;
Wong, Michael K;
Sullivan, Ryan J.
Since the first approval for immune checkpoint inhibitors
(ICIs) for the treatment of cutaneous melanoma more than
a decade ago, immunotherapy has completely transformed
the treatment landscape of this chemotherapy-resistant
disease. Combination regimens including ICIs directed
against programmed cell de...